Summary for Bezafibrate


BreastfeedingGeriatricPediatric
  • Trade Names: Bezalip (Roche); Bezamidin; Cedur; Nimus; Oralipin
  • Indications: Hypercholesterolemia, hyperlipidemia, Type II diabetes
  • Class: Antilipemic, Fibrate
  • Half-life: 1–2 hours
  • See adverse reactions attributed to class:

    Fibrate

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric